SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3.

Craig SchindewolfKumari LokugamageMichelle N VuBryan A JohnsonDionna SchartonJessica A PlanteBirte KalveramPatricia A Crocquet-ValdesStephanea SotcheffElizabeth JaworskiR Elias AlvaradoKari DebbinkMatthew D DaughertyScott C WeaverAndrew L RouthDavid H WalkerKenneth S PlanteVineet D Menachery

Published in: bioRxiv : the preprint server for biology (2022)

methyltransferase inhibitor in combination with type I interferon offers a novel avenue for antiviral development.

Keyphrases

sars cov
respiratory syndrome coronavirus
dendritic cells
protein protein
amino acid